Novartis Vaccines Unit Looks To Make Its Presence With New Technologies

With a variety of new vaccines technology in play - such as cell-culture production, novel adjuvants and reverse vaccinology - Novartis' fledgling vaccines unit is at the cutting edge of vaccine development and could become a major player in the revitalized vaccine field